PARKHILL KAREN L 4
4 · Medtronic plc · Filed Aug 7, 2023
Insider Transaction Report
Form 4
PARKHILL KAREN L
EVP & Chief Financial Officer
Transactions
- Award
Ordinary Shares
2023-08-03+7,105→ 52,246 total - Tax Payment
Ordinary Shares
2023-08-03$84.49/sh−5,919$500,096→ 46,327 total - Exercise/Conversion
Performance Share Units
2023-08-03−7,105→ 0 total→ Performance Share Units (7,105 underlying)
Holdings
- 49,859(indirect: By Trust)
Ordinary Shares
- 843(indirect: By Children)
Ordinary Shares
- 843(indirect: By Children)
Ordinary Shares
- 843(indirect: By Children)
Ordinary Shares
Footnotes (6)
- [F1]Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 9, 2020 and earned dividend equivalents.
- [F2]Includes 723 shares representing earned dividend equivalents upon the settlement of restricted stock units that vested on August 3, 2023 and were previously reported on Table 1.
- [F3]Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units and restricted stock units that vested on August 3, 2023.
- [F4]These shares are held in the Jeffrey S. Parkhill 2021 Irrevocable Trust, of which the insider is the trustee and a beneficiary.
- [F5]Each performance share unit represented a contingent right to receive one share of Medtronic common stock.
- [F6]The performance share units vested on August 3, 2023.